¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"fragment ion"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® pH, hydrogen ion concentration ÇÑ±Û ¼ö¼ÒÀ̿³óµµÁö¼ö
¼³¸í   
  Ç÷¾×À̳ª ¼Òº¯¿¡¼­ ½Ç½ÃÇϴ °Ë»çÇ׸ñ. pH°Ë»ç´Â ÀÎüÀǠü¾×ÀÇ »ê¼º, ¾ËÄ®¸®¼ºÀ» ¾Ë¾Æº¸´Â Áß¿äÇÑ °Ë»çÀÌ´Ù. ÀÎü´Â ¾à¾ËÄ®¸®¼º¿¡ ¼ÓÇϳª, À̺¸´Ù pHÀÇ Áõ°¡³ª °¨¼Ò°¡ ³ªÅ¸³¯ °æ¿ì, »ý¸í¿¡ À§ÇèÀÌ ¹ß»ýÇÑ´Ù. ÀÎü³»¿¡´Â ÀÌ·± »êµµÀÇ Áõ°¨À» ¸·±âÀ§ÇØ, À̸¥¹Ù ¿ÏÃæÁ¦µéÀÌ ¸¹ÀÌ Á¸ÀçÇϸç, Æ¯È÷ ÇãÆÄ¿Í ÄáÆÏÀÌ ¿ÏÃæÀÛ¿ëÀ» ¼öÇàÇϴ ÁÖ¿ä±â°üÀÌ´Ù.
  
  ÄáÆÏÀº »êµµ°¡ ³ôÀ» °æ¿ì, ¼Òº¯¿¡¼­ »êµµ¸¦ Áõ°¡½ÃÄÑ ¹èÃâÇÔÀ¸·Î½á Ç÷¾×³»ÀÇ ¾ËÄ®¸®¼º ³óµµ°¡ Áõ°¡Çϵµ·Ï ÇÑ´Ù. ¶ÇÇÑ ÇãÆÄ¿¡¼­µµ, Ç÷¾×³»¿¡ »êµµ°¡ Áõ°¡½Ã È£ÈíÀ» Áõ°¡ÇÔÀ¸·Î½á ¹ÛÀ¸·Î »êÀÇ ¹èÃâÀ» Áõ°¡½ÃŲ´Ù. ÀÌ·± ÇãÆÄ¿Í ÄáÆÏÀÇ ±ÕÇüÀº ¾ÆÁÖ ÀûÀýÈ÷ ÀÌ·ç¾îÁö°í ÀÖÀ¸¸ç, ¾î´À ÇÑ ±â°üÀÇ ÀÌ»óÀÌ ¹ß»ýÇϸé, ÀÌ·± ±ÕÇüÀº ±ú¾îÁö±â ½±´Ù.
¿µ¹® ion ÇÑ±Û ÀÌ¿Â
¼³¸í   
  ºÐÀÚ¸¦ Àü±âºÐÇØÇÒ ¶§ ºÐ¸®µÇ´Â, Àü±â¸¦ ¶í ¹Ì¸³Àڷμ­ ¾çÀü±â¸¦ ¶í ¾çÀ̿°ú À½Àü±â¸¦ ¶í À½ÀÌ¿ÂÀÌ ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antigen binding fragment
    Ç׿ø°áÇÕºÎÀ§
  • acentric fragment
    ¹«Áß½ÉÀýÁ¶°¢, ¿°»öü´ÜÆí, ¹«Áß½Éü´ÜÆí
  • bone fragment
    »ÄÁ¶°¢, °ñÆí
  • Fc fragment
    FcºÐÀý
  • fallen fragment sign
    ³«ÇÏÆÄÆí¡ÈÄ
  • fracture fragment
    °ñÀýÁ¶°¢, °ñÀýÀýÆí
  • fragment
    Á¶°¢, Æí
  • restriction fragment length polymorphism
    Á¦ÇÑÀýÆí±æÀÌ´ÙÇüÅÂ
  • amphoteric ion
    ¾ç¼ºÀÌ¿Â
  • dipolar ion
    µÎ±ØÀÌ¿Â
  • heavy ion irradiation
    ÁßÀÌ¿ÂÁ¶»ç
  • hydrogen ion
    ¼ö¼ÒÀÌ¿Â
  • hydrogen ion concentration
    ¼ö¼ÒÀ̿³óµµ
  • ion
    ÀÌ¿Â
  • ion channel disorder
    ÀÌ¿ÂÅë·ÎÁúȯ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fragment
    Á¶°¢
  • bone fragment
    »ÄÁ¶°¢
  • ion
    ÀÌ¿Â
  • positive ion
    ¾çÀÌ¿Â
  • ion trapping
    ÀÌ¿ÂÆ÷Âø
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acentric fragment
    ¹«Áß½ÉÀýÁ¶°¢, ¿°»öü´ÜÆí, ¹«Áß½Éü´ÜÆí
  • antigen binding fragment
    Ç׿ø°áÇÕºÎÀ§
  • bone fragment
    »ÀÁ¶°¢, °ñÆí
  • fragment
    Á¶°¢
  • fallen fragment sign
    ³«ÇÏÆÄÆí¡ÈÄ
  • fracture fragment
    °ñÀýÁ¶°¢, °ñÀýÀýÆí
  • restriction fragment length polymorphism
    Á¦ÇÑÀýÆí±æÀÌ´ÙÇü¼º
  • amphoteric ion
    ¾ç¼ºÀÌ¿Â
  • hydrogen ion concentration
    ¼ö¼ÒÀ̿³óµµ
  • ion exchange chromatography
    À̿±³È¯Å©·Î¸¶Åä±×·¡ÇÇ
  • dipolar ion
    ¾ç±ØÀÌ¿Â
  • hydrogen ion exponent
    ¼ö¼ÒÀÌ¿ÂÁö¼ö
  • ion exchanger
    À̿±³È¯Á¦
  • ion selective electrode
    À̿¼±ÅÃÀü±Ø
  • ion gradient
    À̿±â¿ï±â, À̿°æ»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • F(ab) fragment
    F(ab)Á¶°¢
  • Fab fragment
    Fab ºÐÀý.
  • Fab fragment
    Fab Á¶°¢.
  • Fab fragment
    Fab ºÐÀý
  • acentric fragment
    ¿°»öü´ÜÆí, ¹«Áß½Éü´ÜÆí
  • antigen binding fragment
    Ç׿ø°áÇÕºÎÀ§
  • fracture fragment
    °ñÀý Æí(Íéï¹ø¸).
  • fragment
    ¼¼Æí, ÆÄÆí(÷òø¸), ´ÜÆí(Ó¨ø¸), ºÐÀý, ÆíÀý, °ñÆí(Íéø¸).
  • fragment
    ÀýÆí, ºÐÀý, Á¶°¢
  • H+ (Hydrogen ion)
    ¼ö¼ÒÀÌ¿Â
  • Hydrogen ion
    ¼ö¼ÒÀÌ¿Â
  • Hydroxyl ion
    ÇÏÀ̵å·Ï½ÇÀÌ¿Â
  • Ion gradient
    À̿°æ»ç(ÌËÞØ)
  • air ion
    °ø±âÀÌ¿Â.
  • amphoteric ion
    ¾ç¼ºÀÌ¿Â.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acentric fragment
    ¿°»öü´ÜÆí, ¹«Áß½Éü´ÜÆí
  • antigen binding fragment
    Ç׿ø°áÇÕºÎÀ§
  • bone fragment
    °ñÆí(Íéø¸), °ñ Á¶°¢.
  • detached fragment
    À¯¸®(°ñ)Æí(ë´ìÆÍéø¸).
  • fallen fragment sign
    ³«ÇÏ ÆÄÆí ¡ÈÄ
  • fracture fragment
    °ñÀý Æí(Íéï¹ø¸).
  • fragment
    ÀýÆí, ºÐÀý, Á¶°¢
  • fragment
    ¼¼Æí, ÆÄÆí(÷òø¸), ´ÜÆí(Ó¨ø¸), ºÐÀý, ÆíÀý, °ñÆí(Íéø¸).
  • restriction fragment length polymorphism
    Á¦ÇѼ¼Æí±æÀÌ´ÙÇü¼º(ð¤ùÚ¼¼Æí¡­Òýû¡à÷)
  • restriction fragment length polymorphism,in cystic fibrosis
    ³¶¼º¼¶À¯Áõ(ÀÇ)¡­(Ò¥àõàéë«ñø¡­)
  • restriction fragment length polymorphism analysis
    Á¦ÇÑÀý´Ü±æÀÌ´ÙÇüÁõºÐ¼®
  • restriction fragment length polymorphism=RFLP
    Á¦ÇÑÀýÆí±æÀ̴پ缺
  • urinary gonadotropin fragment/peptide
    ¿äÁß¼º¼±ÀÚ±ØÈ£¸£¸óºÐÀý/ÆéƼµå
  • air ion
    °ø±âÀÌ¿Â.
  • amphoteric ion
    ¾ç¼ºÀÌ¿Â.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fragment ion
    Á¶°¢ ÀÌ¿Â
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ion-ion interaction
    ÀÌ¿Â-À̿ »óÈ£ÀÛ¿ë(ßÓû»íÂéÄ)
  • antigen-binding fragment
    Ç׿ø°áÇÕ(ù÷ê«Ì¿ùê) Á¶°¢
  • crystallizable fragment
    "°áÁ¤(Ì¿ïÜ) Á¶°¢, (ÔÒ) fc fragment"
  • Fab fragment
    Fab Á¶°¢
  • Fab' fragment
    Fab' Á¶°¢
  • F(ab')2 fragment
    F(ab')2 Á¶°¢
  • Fc fragment
    Fc Á¶°¢
  • Fd fragment
    Fd Á¶°¢
  • Fd' fragment
    Fd' Á¶°¢
  • (F1+F2) fragment
    (F1 + F2) Á¶°¢
  • F1 fragment
    F1 Á¶°¢
  • F2 fragment
    F2 Á¶°¢
  • F3 fragment
    F3 Á¶°¢
  • fragment length mapping
    Á¶°¢ ±æÀÌ ÀÛµµ(íÂÓñ)
  • fragment map
    Á¶°¢ Áöµµ(ò¢Óñ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bone fragment
    °ñÆí
  • fragment
    ¼¼Æí, ÆÄÆí, ´ÜÆí, ºÐÀý, ÆíÀý, °ñÆí
  • gelfoam fragment
    Á©Æû Á¶°¢
  • ion
    ÀÌ¿Â
  • ion chamber
    Àü¸®ÇÔ
  • ion pair
    À̿½Ö
  • paramagnetic ion
    »óÀÚ¼ºÀÌ¿Â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
g-ion gram-ion
ISS idiopathic short stature; injury severity score; International Society of Surgery; ion-scattering sp...
RFLPs Restriction Fragment Length Polymorphisms; Á¦ÇÑÈ¿¼Ò´ÜÆíÀå´ÙÇü
UGF Urinary Gonadotropin Fragment
B3F band 3 cytoplasmic fragment
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AFLP Amplified Fragment Length Polymorphism
CTF C-terminal fragment
FAFLP Fluorescent Amplified Fragment Length Polymorphism
HTF Hpa II tiny fragment
KF Klenow fragment
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • hydrogen ion
    ¼ö¼Ò ÀÌ¿Â
    ¼ö¼Ò ¿øÀÚÀÇ ÇÙ ¶Ç´Â ÀüÀÚ¸¦ »ó½ÇÇÑ ¼ö¼Ò ¿øÀÚ. À̰ÍÀº ÀüÀÚÀÇ À½ ÀüÇÏ¿Í µ¿·®ÀÇ ¾ç ÀüÇϸ¦ °¡Áø´Ù.
  • hydrogen ion exchange
    ¼ö¼Ò À̿ ±³È¯
  • hydronium ion
    ¿Á¼Ò´½ ÀÌ¿Â
    ÇÏÀ̵å·Î´½.
  • hydroxy ion
    ¼ö»ê±â ÀÌ¿Â
  • ion
    ÀÌ¿Â
    ¾ç ¶Ç´Â À½ Àü±â¸¦ ¶ì´Â ¿øÀÚ³ª ¿øÀÚ´ÜÀ» ÅëÆ²¾î °¡¸®Å°´Â ¸».
  • ion channel
    À̿ Åë·Î
    ¼¼Æ÷¸· µî¿¡ Á¸ÀçÇϸç ÀÚ±ØÀÌ ¿À¸é Åë·Î¸¦ ¿­°í, ´ÝÀ½À¸·Î ÇØ¼­ ÀÌ¿ÂÀÇ ³óµµ¸¦ Á¶ÀýÇØ¼­ ÀÚ±ØÀÇ Àü´Þ¿¡ °ü¿©ÇÑ´Ù.
  • ion exchange
    À̿ ±³È¯
  • ion exchange strengthening
    À̿ ±³È¯ °­È­
  • ion pair
    À̿½Ö
  • negative ion
    À½ ÀÌ¿Â
  • amino fragment
    ¾Æ¹Ì³ë ÀýÆí
  • antigen binding fragment
    Ç׿ø °áÇÕ ºÎÀ§
  • bone fragment
    °ñÆí
  • carboxy fragment
    ź¼Ò ÀýÆí
  • detached fragment
    À¯¸®Æí, À¯¸® °ñÆí
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
acentric fragment A fragment of a chromosome lacking a centromere and unable to attach to the mitotic spindle, therefore unable to take part in the division of a nucleus and randomly distributed in daughter cells.
Synonym: acentric fragment.
(05 Mar 2000)
amplified fragment length polymorphism <technique> Invented by KeyGene, a Dutch biotech company based in Wageningen, Holland. The technique is now merchandised under licence agreement by Perkin Elmer.
Selected markers are amplified in a PCR, which makes amplified fragment length polymorphism an easy and fast tool for strain identification in agriculture, botany, microbiology and animal breeding.
Acronym: AFLP
(05 Feb 1998)
Brimacombe fragment A ribonucleoprotein fragment obtained by mild ribonuclease treatment of ribosomes.
(05 Mar 2000)
butterfly fragment A broad triangular fragment that is commonly present in comminuted fractures of the diaphysis.
(05 Mar 2000)
restriction fragment <molecular biology> The fragments of DNA generated by digesting DNA with a specific restriction endonuclease. Each of the fragments ends in a site recognised by that specific enzyme.
(10 Mar 1998)
restriction fragment length polymorphism <molecular biology, technique> A method that allows familial relationships to be established by comparing the characteristic polymorphic patterns that are obtained when certain regions of genomic DNA are amplified (typically by PCR) and cut with certain restriction enzymes.
The variation in the length of DNA fragments produced by a restriction endonuclease that cuts at a polymorphic locus. Such variations are generated by mutations that create or abolish recognition sites for these enzymes.
This is a key tool in DNA fingerprinting, reflecting the existence of different alleles in the individual. Restriction fragment length polymorphism mapping is also used in plant breeding to see if a key trait such as disease resistance is inherited.
In principle, an individual can be identified unambiquously by restriction fragment length polymorphism hence the use of restriction fragment length polymorphism in forensic analysis of blood, hair or semen).
Similarly, if a polymorphism can be identified close to the locus of a genetic defect, it provides a valuable marker for tracing the inheritance of the defect.
Synonym: DNA fingerprinting.
Acronym: RFLP
(12 Jan 1998)
Okazaki fragment A relatively short (100-1000 bp) fragment of DNA that is later joined by DNA ligase to allow for 3' &rarr; 5' overall chain growth during replication.
(05 Mar 2000)
one-carbon fragment The formyl group or the methyl group that takes part in transformylation or transmethylation reactions; by means of these reactions, a group containing a single carbon atom is added to a compound being biosynthesised, adding a methyl group (as in thymidine formation), adding a hydroxymethyl group (as in serine biosynthesis), or closing a ring (as in purine formation).
(05 Mar 2000)
two-carbon fragment The acetyl group (CH3CO-) that takes part in transacetylation reactions with coenzyme A as carrier; commonly referred to as acetate or acetic acid, from which it is derived.
(05 Mar 2000)
f2 fragment <immunology> A fragment of an antibody protein which includes the antigen-binding portions but not the Fc section. They can be produced by treating whole antibodies with proteases that will specifically cleave off the Fc section.
(09 Oct 1997)
Fab fragment The antigen-binding fragment of an immunoglobulin molecule, consisting of both a light chain and part of a heavy chain.
Synonym: Fab piece.
(05 Mar 2000)
Fc fragment <immunology> The constant region on an immunoglobulin molecule. The area that is exactly the same on all antibodies. The region is found on the heavy chains and is not involved in binding antigens.
(09 Oct 1997)
Klenow fragment <molecular biology> Larger part of the bacterial DNA polymerase I (76 kD) that remains after treatment with subtilisin, retains some but not all exonuclease and polymerase activity.
(18 Nov 1997)
fragment A small part broken from a larger entity.
(05 Mar 2000)
fragment reaction A reaction used to assay the activity of peptidyl transferase.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fission fragment
    Çٺп­ÀÇ ÆÄÆí
  • fragment
    ÆÄÆí;´ÜÆí;¹Ì¿Ï¼º À¯°í;ºÎ¼­Áø Á¶°¢;»ê»êÀÌ ºÎ¼ö´Ù;»ê»ê Á¶°¢ÀÌ µÇ´Ù;ºÎ¼­Áö´Ù
  • -ion
    ¶óƾ¾î°èµ¿»ç ¾î¹Ì¿¡ ºÙ¾î¼­ (»óÅÂ,µ¿ÀÛ)À» ³ªÅ¸³»´Â ¸í»ç ¾î¹Ì
  • field ion microscope
    À̿ ¹æ»ç Çö¹Ì°æ;Àü°è À̿ Çö¹Ì°æ
  • hydrogen ion
    ¼ö¼ÒÀÌ¿Â
  • ion
    (È­)ÀÌ¿Â;¾çÀÌ¿Â(cation);À½ÀÌ¿Â(anion)
  • ion engine
    (°ø)À̿¿£Áø(ion rocket)
  • ion etching
    (¹°)À̿¿¡Äª(±Ý¼Óµî¿¡ °í¿¡³ÊÁö ÀÌ¿ÂÀ» ÂØ¾î ºÎ½Ä½Ã۱â)
  • ion exchange
    (¹°,È­)À̿±³È¯
  • ion implantation
    (¹°)À̿ ÁÖÀÔ(¹ý)(¹ÝµµÃ¼¸¦ ¾ò´Â ¹æ¹ýÀÇ Çϳª)
  • ion milling
    ION ETCHING
  • ion propulsion
    (¿ìÁÖ¼± µîÀÇ)À̿ ÃßÁø
  • ion rocket
    ION ENGINE
  • positive ion
    ¾çÀÌ¿Â
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á